Oscar Health Sees Unusually Large Options Volume (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) was the target of unusually large options trading on Friday. Stock traders purchased 13,581 put options on the company. This is an increase of approximately 35% compared to the typical daily volume of 10,049 put options.

Insiders Place Their Bets

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company’s stock, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 24.39% of the company’s stock.

Institutional Trading of Oscar Health

A number of hedge funds and other institutional investors have recently modified their holdings of OSCR. Jones Financial Companies Lllp grew its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Larson Financial Group LLC raised its stake in Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after purchasing an additional 2,512 shares during the period. CWM LLC raised its stake in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after purchasing an additional 1,078 shares during the period. Caitong International Asset Management Co. Ltd grew its holdings in shares of Oscar Health by 484.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after acquiring an additional 2,854 shares in the last quarter. Finally, Cliffwater LLC purchased a new position in shares of Oscar Health during the 1st quarter valued at $58,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several recent analyst reports. Wall Street Zen lowered Oscar Health from a “buy” rating to a “hold” rating in a research report on Thursday. Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health currently has a consensus rating of “Hold” and an average target price of $20.08.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $14.14 on Friday. The business’s fifty day moving average price is $13.66 and its two-hundred day moving average price is $14.58. The stock has a market cap of $3.54 billion, a PE ratio of -706.65 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the company posted $0.62 earnings per share. The firm’s revenue was up 42.2% compared to the same quarter last year. On average, analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.